Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Porcine Vaccines market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Porcine Vaccines market segmented into
Live Attenuated Vaccines
Inactivated Vaccines
Others
Based on the end-use, the global Porcine Vaccines market classified into
Swine Fever Vaccines
Swine Flu Vaccines
Porcine Circoviruses
Others
Based on geography, the global Porcine Vaccines market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
WINSUN
CAHIC
Merial
MSD Animal Health (Merck)
Chopper Biology
Ceva
ChengDu Tecbond
HVRI
Ringpu Biology
Qilu Animal Health
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
18Institutul Pasteur
MVP
Tecon
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Porcine Vaccines market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Porcine Vaccines market segmented into
Live Attenuated Vaccines
Inactivated Vaccines
Others
Based on the end-use, the global Porcine Vaccines market classified into
Swine Fever Vaccines
Swine Flu Vaccines
Porcine Circoviruses
Others
Based on geography, the global Porcine Vaccines market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
WINSUN
CAHIC
Merial
MSD Animal Health (Merck)
Chopper Biology
Ceva
ChengDu Tecbond
HVRI
Ringpu Biology
Qilu Animal Health
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
18Institutul Pasteur
MVP
Tecon
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PORCINE VACCINES INDUSTRY
2.1 Summary about Porcine Vaccines Industry
2.2 Porcine Vaccines Market Trends
2.2.1 Porcine Vaccines Production & Consumption Trends
2.2.2 Porcine Vaccines Demand Structure Trends
2.3 Porcine Vaccines Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Live Attenuated Vaccines
4.2.2 Inactivated Vaccines
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Swine Fever Vaccines
4.3.2 Swine Flu Vaccines
4.3.3 Porcine Circoviruses
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Live Attenuated Vaccines
5.2.2 Inactivated Vaccines
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Swine Fever Vaccines
5.3.2 Swine Flu Vaccines
5.3.3 Porcine Circoviruses
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Live Attenuated Vaccines
6.2.2 Inactivated Vaccines
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Swine Fever Vaccines
6.3.2 Swine Flu Vaccines
6.3.3 Porcine Circoviruses
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Live Attenuated Vaccines
7.2.2 Inactivated Vaccines
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Swine Fever Vaccines
7.3.2 Swine Flu Vaccines
7.3.3 Porcine Circoviruses
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Live Attenuated Vaccines
8.2.2 Inactivated Vaccines
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Swine Fever Vaccines
8.3.2 Swine Flu Vaccines
8.3.3 Porcine Circoviruses
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Live Attenuated Vaccines
9.2.2 Inactivated Vaccines
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Swine Fever Vaccines
9.3.2 Swine Flu Vaccines
9.3.3 Porcine Circoviruses
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 WINSUN
10.1.2 CAHIC
10.1.3 Merial
10.1.4 MSD Animal Health (Merck)
10.1.5 Chopper Biology
10.1.6 Ceva
10.1.7 ChengDu Tecbond
10.1.8 HVRI
10.1.9 Ringpu Biology
10.1.10 Qilu Animal Health
10.1.11 DHN
10.1.12 CAVAC
10.1.13 Komipharm
10.1.14 Agrovet
10.1.15 Bioveta
10.1.16 Jinyu Bio-Technology
10.1.17 18Institutul Pasteur
10.1.18 MVP
10.1.19 Tecon
10.2 Porcine Vaccines Sales Date of Major Players (2017-2020e)
10.2.1 WINSUN
10.2.2 CAHIC
10.2.3 Merial
10.2.4 MSD Animal Health (Merck)
10.2.5 Chopper Biology
10.2.6 Ceva
10.2.7 ChengDu Tecbond
10.2.8 HVRI
10.2.9 Ringpu Biology
10.2.10 Qilu Animal Health
10.2.11 DHN
10.2.12 CAVAC
10.2.13 Komipharm
10.2.14 Agrovet
10.2.15 Bioveta
10.2.16 Jinyu Bio-Technology
10.2.17 18Institutul Pasteur
10.2.18 MVP
10.2.19 Tecon
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PORCINE VACCINES INDUSTRY
2.1 Summary about Porcine Vaccines Industry
2.2 Porcine Vaccines Market Trends
2.2.1 Porcine Vaccines Production & Consumption Trends
2.2.2 Porcine Vaccines Demand Structure Trends
2.3 Porcine Vaccines Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Live Attenuated Vaccines
4.2.2 Inactivated Vaccines
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Swine Fever Vaccines
4.3.2 Swine Flu Vaccines
4.3.3 Porcine Circoviruses
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Live Attenuated Vaccines
5.2.2 Inactivated Vaccines
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Swine Fever Vaccines
5.3.2 Swine Flu Vaccines
5.3.3 Porcine Circoviruses
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Live Attenuated Vaccines
6.2.2 Inactivated Vaccines
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Swine Fever Vaccines
6.3.2 Swine Flu Vaccines
6.3.3 Porcine Circoviruses
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Live Attenuated Vaccines
7.2.2 Inactivated Vaccines
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Swine Fever Vaccines
7.3.2 Swine Flu Vaccines
7.3.3 Porcine Circoviruses
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Live Attenuated Vaccines
8.2.2 Inactivated Vaccines
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Swine Fever Vaccines
8.3.2 Swine Flu Vaccines
8.3.3 Porcine Circoviruses
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Live Attenuated Vaccines
9.2.2 Inactivated Vaccines
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Swine Fever Vaccines
9.3.2 Swine Flu Vaccines
9.3.3 Porcine Circoviruses
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 WINSUN
10.1.2 CAHIC
10.1.3 Merial
10.1.4 MSD Animal Health (Merck)
10.1.5 Chopper Biology
10.1.6 Ceva
10.1.7 ChengDu Tecbond
10.1.8 HVRI
10.1.9 Ringpu Biology
10.1.10 Qilu Animal Health
10.1.11 DHN
10.1.12 CAVAC
10.1.13 Komipharm
10.1.14 Agrovet
10.1.15 Bioveta
10.1.16 Jinyu Bio-Technology
10.1.17 18Institutul Pasteur
10.1.18 MVP
10.1.19 Tecon
10.2 Porcine Vaccines Sales Date of Major Players (2017-2020e)
10.2.1 WINSUN
10.2.2 CAHIC
10.2.3 Merial
10.2.4 MSD Animal Health (Merck)
10.2.5 Chopper Biology
10.2.6 Ceva
10.2.7 ChengDu Tecbond
10.2.8 HVRI
10.2.9 Ringpu Biology
10.2.10 Qilu Animal Health
10.2.11 DHN
10.2.12 CAVAC
10.2.13 Komipharm
10.2.14 Agrovet
10.2.15 Bioveta
10.2.16 Jinyu Bio-Technology
10.2.17 18Institutul Pasteur
10.2.18 MVP
10.2.19 Tecon
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
